GlassScriptPhysician profile
Bryan C Myers
NPI 1548331275
$2,287.52
in general payments reported to CMS, 2019-2025
33 companies · $633 in 2025
The $633 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $176 · 2021: $474 · 2022: $215 · 2023: $308 · 2024: $362 · 2025: $633.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,302.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $426.64 | 2020-2025 | Solyx Sis System, Bulkamid - Bulkamid Urethral Bulking Pack 2ml (Ous), Bulkamid |
| Sage Therapeutics, LLC | $253.91 | 2024-2025 | Zurzuvae |
| Aspira Women'S Health INC | $219.39 | 2021-2023 | Ova1 |
| Caldera Medical, INC | $195.25 | 2021 | |
| Abbvie INC. | $119.18 | 2020-2025 | |
| Astellas Pharma US INC | $102.78 | 2023-2025 | Veozah |
| Channel Medsystems, INC. | $87.03 | 2021 | |
| Exeltis, USA INC. | $81.03 | 2024-2025 | Slynd |
| Coopersurgical, INC. | $80.34 | 2019-2023 | Endosee |
| Coloplast Corp | $78.26 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $70.08 | 2024-2025 | Gemtesa |
| Baxter Healthcare | $52.71 | 2023-2024 | Perclot, Floseal |
| Novo Nordisk INC | $41.26 | 2023 | Wegovy |
| Hologic Sales and Service, LLC | $39.31 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $37.79 | 2022-2024 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $37.35 | 2025 | Qelbree |
| Shield Therapeutics INC | $37.03 | 2025 | |
| Pfizer INC. | $36.24 | 2025 | |
| Minerva Surgical, INC | $34.28 | 2019-2024 | |
| Allergan, INC. | $31.79 | 2019 | |
| Organon LLC | $24.10 | 2025 | Nexplanon |
| Mylan Pharmaceuticals INC. | $23.04 | 2019-2021 | |
| Daiichi Sankyo INC. | $22.49 | 2021 | |
| Ethicon US, LLC | $18.70 | 2024 | Surgicel Nu-Knit, Harmonic, Ethicon |
| Bayer Healthcare Pharmaceuticals INC. | $17.55 | 2021 | |
| Olympus America INC. | $17.43 | 2019 | |
| Duchesnay USA Incorporated | $16.94 | 2019 | |
| Exact Sciences Corporation | $16.75 | 2025 | The Cologuard Plus Collection Kit |
| Vertex Pharmaceuticals Incorporated | $15.44 | 2025 | |
| Urovant Sciences INC | $14.75 | 2022 | |
| Smith+Nephew, INC. | $13.65 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.06 | 2023 | Seglentis |
| Evofem Biosciences, INC. | $11.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Myers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.